Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_assertion type Assertion NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_head.
- NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_assertion description "[Cultured human epithelial ovarian cancer cell line A2780 and its platinum(DDP)-resistance cell line A2780/DDP were divided into three groups as control, treatment with DDP, and treatment with Taxol Expression of mdr1 and survivin genes in each group was detected by using reverse transcription-polymerase chain reaction (RT-PCR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_provenance.
- NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_assertion evidence source_evidence_literature NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_provenance.
- NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_assertion SIO_000772 15970709 NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_provenance.
- NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_assertion wasDerivedFrom befree-2016 NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_provenance.
- NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_assertion wasGeneratedBy ECO_0000203 NP500498.RAVOMWdpTB5wCt5zctflUT5VCHhmLfydVNkKrq7g-XuSw130_provenance.